Sun et al45 found that a low level of KLF3 is associated with the poor prognosis of lung cancer, and KLF3 could alter the epithelial‐mesenchymal transition by controlling STAT3, ultimately affecting metastasis. Here, STAT3 is linked to lung carcinoma.